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ABSTRACT 
 
Introduction: Pre eclampsia is a progressive disorder, in some circumstances; delivery is needed to halt the 
progression to the benefit of the mother and fetus. Aim: This study is designed to evaluate the incidence and effect 
of current interventional strategy for severe pre-eclampsia on maternal and perinatal outcome. Materials and 
methods: This is a cross-sectional study in Obstetrical and Gynecological department at Modern Govt. maternity 
hospital Hyderabad from January to August over a period of 8 months with sample size 285 cases in among 14085 
deliveries. Cases were studied in relation to age, parity, level of antenatal care, gestational age, BP at the time of 
admission, investigations, complications, mode of delivery, mode of induction and perinatal outcome in all these 
cases. Results:  Among 14085 deliveries in 8 months we had  285 pre-eclampsia cases, incidence percentage being 
2.03%. Majority of women were in the age group of 20-25 yrs and majority of women gestational age >34 weeks. 
Almost half of the twin preeclampsia cases were unbooked cases. Majority of cases are in Primigravidae. Among 
285cases, vaginal delivery occurred in 64% cases and LSCS in 37% cases. Severe pre-eclampsia is seen in all blood 
pressures. BP is controlled by giving oral Nifedepine, IV labetol and magnesium sulphate in all cases. Perinatal 
mortality is high with birth weight <1 kg in both vaginal and LSCS. In LSCS Total PNMR is 15.12%, while in 
induced vaginal delivery and non induced vaginal delivery PNMR is 42.2%, 37% respectively. According to 
gestational age total PNMR LSCS is12.26%, where as PNMR in induced vaginal delivery is 42.2% and in non 
induced cases PNMR is 37%. Maternal mortality rate observed is 2.1%, causes being pulmonary embolism, acute 
LVF, ARDS and DIC. Conclusion: Incidence of severe pre-eclampsia is 2.03% in deliveries, seen commonly in 
young women below 25 yrs of age, nulliparous, with no antenatal care and was seen maximum after 34 weeks of 
pregnancy.  Many patients came with various complications which were efficiently managed by stabilizing and 
delivering them early. The BP was well controlled with Nifedepine or Labetalol and Magnesium sulphate in all 
cases. 
 
Key words: Pre eclampsia, PIH, Perinatal mortality, Maternal mortality. 
Introduction 
Gestational hypertension/pre-eclampsia is the most 
common obstetrical complication of pregnancy, with a 
reported incidence of approximately 10%[1].Most 
cases of gestational hypertension/pre-eclampsia 
develop in healthy nulliparous women, with a reported 
incidence in this group of 26%-29%[2,3].Gestational 
hypertension/pre-eclampsia is a syndrome that is 
characterized by heterogeneous clinical, radiologic, and 
laboratory findings. The clinical findings of pre- 
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eclampsia can manifest as either a maternal syndrome 
or a fetal syndrome in the form of fetal growth 
restriction, oligohydramnios abruptio placentae, 
abnormal umbilical artery Doppler findings, and 
reduced placental weight with infarctions and abruptio 
placentae[4]. In some patients, particularly those with 
severe early onset pre-eclampsia the clinical findings 
can affect both the mother and the fetus[5]. Gestational 
hypertension-pre-eclampsia can be associated with 
serious maternal and perinatal complications (both 
acute and long term)[6]. The risk of these 
complications will depend on severity of the disease 
process, gestational age at onset, fetal and maternal 
conditions at time of diagnosis, and timing of delivery. 
The primary objective of management in pregnancies 
complicated by gestational hypertension or pre-
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eclampsia must always be safety of the mother and the 
fetus, and then if possible, delivery of a mature 
newborn that will not require admission to a neonatal 
intensive care unit. Neonatal survival depends on 
gestational age at delivery and is low in small-for-
gestational age babies. The purpose of this study is to 
evaluate the incidence and clinical profile of pre- 
eclampsia patients and the effect of current 
interventional strategy for severe pre-eclampsia on 
maternal and perinatal outcome. 
 
Materials and methods 
 
This is a cross-sectional study which analysed 
protocols of births during 2010, in Obstetrical and 
Gynecological department at Modern Govt. maternity 
hospital Hyderabad from January to August to evaluate 
incidence and clinical profile of severe pre-eclampsia 
patients and the effect of current interventional strategy 
for severe pre-eclampsia on maternal and perinatal 
outcome at tertiary medical center which would enable 
us to review the efficiency of our management. 285 
cases of pregnancies were studied over a period of 8 
months in among 14065 deliveries. A pre-tested 
interviewer-administered structured questionnaire was 
developed after reviewing different related literatures 
to collect the data. The questionnaire prepared was 
used to collect the data. Three Obstetrics and 
Gynecology residents, one pediatrics resident, one 
midwife nurse and two medical interns were recruited, 
trained to collect the required data from the mothers. 
The training was given for three days on the objective, 
relevance of the study, confidentiality of information, 
respondent’s right, informed consent and techniques of 
interview. All completed questionnaires were reviewed 
each night and morning sessions were conducted every 
day with the data collectors to discuss on the problem 
encountered during data collection procedures.Cases 
were studied in relation to age, parity, level of antenatal 
care, gestational age, BP at the time of admission, 
investigations, complications, mode of delivery, mode 
of induction and perinatal outcome in all these cases. 
Medical records were also reviewed for some clinical 
and laboratory results including proteinuria. The 
participants were allowed to take rest for ten minutes 
before the blood pressure had been measured. Blood 
pressure readings were taken while the woman was 
seated in the upright position using a mercury 
sphygmomanometer apparatus which covers two-thirds 
of the upper arm. The measurement was taken from 
participant’s right hand. The cuff was inflated at a rate 
of 2–3 mmHg per second. Systolic blood pressure 
(SBP) was taken up on hearing the first sound, and 
diastolic blood pressure (DBP) was taken up on 
4th (muffled) Korotkoff sound. Those pregnant women 
with abnormal findings were checked again after 4–6 
hours in order to confirm the diagnosis. However, 
when a pregnant woman found to have severe 
preeclampsia (BP of 160/110 mmHg), she was sent for 
immediate re-checkup and medical advice. Data 
regarding proteinuria and other clinical data were 
accessed from the women’s medical records. 
Proteinuria was assessed using urine dipstick method 
and was part of the routine investigation for all 
pregnant women. Laboratory investigations includes 
CBP with peripheral smear, Platelet Count, RBS, AST, 
ALT, LDH, Serum Creatinine , Plasma Fibrinogen, 
APTT, Ultrasound – Doppler were done.Before 
conduct of the study, ethical clearance was obtained 
from the College. Written informed consent was 
obtained from every study participant before the 
interview by explaining the objective of the research. 
All the information collected from the study 
participants were handled confidentially through 
omitting their personal identification, conducting the 
interview in private place and using the data for the 
research purpose only.The collected data were coded 
and entered to SPSS for windows version for cleaning 
and analysis. Descriptive statistics (means and 
proportions) were used to describe the main features of 
the data. The incidence of pre eclampsia was expressed 
in rates per 1000 deliveries.  
 
Results 
 
This is a study of 285 cases of severe pre-eclampsia 
over a period of 8 months out of 950 cases of PIH in14, 
065 deliveries at our hospital. Incidence in our study is 
2.03.The peak age incidence was the 20-25 year group, 
which accounted for 187 (65%) cases. Most of the 
cases 142/285 (49%) are in Primigravidae. (Table 1). 
Almost half of pre eclampsia cases were unbooked 
cases.  Out of the pre eclampsia cases 169/285(59%) 
were unbooked cases where as116/285(40%) were 
booked cases. 
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Table  1: Age and Parity Distribution 
 
Feature No.of Patients(N-285) Perecntage 
Age distribution in years 
<20 yrs 28 9 
20-25 yrs 187 59 
26-30 yrs 63 22 
>30 yrs 7 2.4 
Parity  
Primigravidae 142 49 
G2 77 27 
G3 43 15 
G4 11 3.8 
>G4 12 4.2 
 
Out of 285 cases, 30(10.5%) cases were in between < 8 
weeks gestational age, 80(28% ) cases were in 28-34 
weeks and 175 (61% ) cases were  in >34 weeks. 
Majority of pre-eclampsia cases were in >34 weeks 
gestational age, hence, close monitoring of pre-
eclampsia cases to be done near term.Vaginal 
deliveries occurred in 180 cases in that 30(10.5%) 
cases being <8 weeks gestational age, 70(38.8%) cases 
were with 28-34 weeks gestational age and 80(44.4%) 
case were in >34 weeks gestational age. Caesarean 
delivery occurred in 105 cases, in that 10(9.5%) cases 
were in 8-34 weeks gestational age whereas 95(90.4%) 
cases were with >3 weeks gestational age. (Table 2)  
 
Table  2: Gestational age and mode of delivery 
 
Variable No.of Patients(N-285) Perecntage 
Gestational age 
<28 weeks 30 10.5 
28-34 weeks 80 28 
>34 weeks 175 61 
Vaginal deliveries (n-180) 
<28 weeks 30 16.5 
28-34 weeks 70 38.8 
>34 weeks 80 44.4 
Caesarean section (105) 
28-34 weeks 10 9.5 
>34 weeks 95 90.4 
 
Out of 285 cases, 66(23%) women had diastolic BP <100 mm Hg, 160(56%) women had diastolic BP in between 
100-110 whereas 59(20.7%) women reported with diastolic BP >110 mm of Hg.  PIH investigations found normal 
in 171(60%) cases whereas abnormal in 64(22%) cases.  
 
Table  3: Blood pressure on admission 
 
Variable No of Patients Percentage 
Blood pressure in mm Hg (diastolic) 
<100 66 23 
100-110 160 56 
>110 59 20.7 
PIH investigations 
Normal  171 60 
Abnormal  64 22 
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Table  4:  Perinatal mortality according to gestational age 
 
Gestational age         LSCS  Vaginal  GrandTotal  
  Induced  Non-induced   
 Alive  Dead  Total  Alive  Dead  Total  Alive  Dead  Total   
<28  -  -  0  0  19  19  0  8  8  27  
28-34  7  5  12  9  13  22  29  20  49  83  
>34  86  8 (8.5%)) 94  43  6(12.2%)  49  27  5 (15.6%) 32  175  
Total  93  13(12%) 106  52  38(42%)  90  56  33(37%)  89  285  
 
Perinatal mortality was seen in 5 cases with birth 
weight of 1.1-1.5 kgs and in 4 cases with birth weight 
1.6-2 kgs by caesarean delivery. Perinatal mortality 
was seen in 19 cases with induced vaginal delivery 
birth weight <1.0 kg and 13 cases with birth weight of 
1.1-1.5 kgs. Where as in non induced vaginal delivery 
11 cases with birth weight of 1.1-1.5 kgs were seen and 
9 cases with birth weight of 1.6-.0 kgs were seen. 
Perinatal mortality was seen in 8 cases by LSCS with 
gestational age of >34 weeks and 5 cases with 
gestational age 28-34 weeks.In induced vaginal 
delivery 19 cases were seen with gestational age <28 
weeks and 13 cases with 28-34 weeks. Where as in non 
induced vaginal delivery, 20 cases were seen with 
gestational age of 28-34 weeks and 8 cases with <28 
weeks were seen. (table 4) 
Table   5: maternal mortality in pre eclampsia cases 
 
Variable No of patients Percentage 
Maternal mortality (n-6) 
Booked cases 1 16 
Unbooked cases 5 83 
Causes  
Pulmonary embolism 3 50 
Acute lvf 1 16 
Ards 1 16 
Dic 1 16 
 
Maternal mortality rate observed in 6/285(2.1%) cases, 
in which 5/6 (83%) cases were unbooked and 1(16%) 
case was booked case.  Causes for maternal mortality 
were pulmonary embolism in 3(50%) cases, acute LVF 
in 1(16%) case, ARDS in 1(16%) case and DIC in1 
(16%) case. (table 5) 
 
Discussion 
 
Pre-eclampsia is one of the leading causes of adverse 
maternal and child outcomes. Incidence of severe pre 
eclampsia was 2.03% in our study and similar results 
are found in a study by Swain et al[7] was 2.2%The 
incidence of eclampsia is very low within developed 
countries with a range of 0.29% - 0.75%, due to the 
provision of standard antenatal care for most pregnant 
women in these countries[8].The observed difference 
in incidences among the aforementioned areas could be 
explained by geographical variability, access to health 
care services and medical attention provided for 
patients.The peak age incidence was the 20-25 year 
group, which accounted for 65% cases Most of the 
cases 49% are in Primigravidae with no antenatal care 
and were seen maximum after 34 weeks (61%) of 
pregnancy.Most of the pre eclampsia cases 63% were 
carried out by vaginal delivery which is differed from 
the study results by Ndaboine et al[9].The NHBPEP 
Working Group Report on High BP in Pregnancy and 
the American College of Obstetrics and Gynecology 
(ACOG) guidelines recommend treatment in 
preeclampsia when the diastolic BP (DBP) is 
persistently above 105–110 mm Hg. Most experts 
agree that pharmacologic therapy should be initiated 
when the BP approaches 150/100 mm Hg with the goal 
of preventing cerebral and cardiovascular events in the 
mother[10]. 
Most of the hypertensive were controlled in this study 
by: 
1) Oral Nifedepine - Up to 30 mg, starting with 10 mg 
can be repeated every 15-30 minutes till B.P. is 
controlled. In a small trial of pre eclamptic mothers 
who received Nifedepine versus placebo, there were 
significant reductions in maternal BP, serum creatinine 
and urea values, and 24-hour urinary protein 
measurements, without a reduction in umbilical artery 
blood flow[10].  
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2) I.V. Labetalol - Many were controlled by 30mg; 
maximum up to 120 mg was given. Labetalol has been 
compared to methyldopa in prospective trials and neither 
medication was associated with adverse maternal or fetal 
outcomes[10].  
3) Magnesium sulphate was given to all patients. 
Magnesium sulfate has been shown to decrease the risk of 
eclampsia and maternal death without evidence of 
significant harm to the mother or baby[10]. 
A significant number of low birth weight neonates might 
have been the result of the high number of preterm 
deliveries among the eclamptic patients. 
Perinatal mortality is high with birth weight <1 kg in both 
vaginal and LSCS.In LSCS Total PNMR is 15.12%, 
Corrected PNMR is 8.5%.  LSCS group showed better 
outcome than vaginal group, especially in low birth 
weight babies. Hence, fetuses with good birth weight were 
left for vaginal delivery.In induced vaginal delivery Total 
PNMR is 42.2%, corrected PNMR is 11.76% where as in 
non induced vaginal delivery total PNMR is 37.08%, 
corrected PNMR is 22.2%.(Table 5)  Perinatal outcome is 
better as the fetal weight is increasing. In this study, 27 
cases with gestational age <28 weeks and 38 cases with 
gestational age 28-34 weeks were reported with adverse 
outcomes. In LSCS Total PNMR is12.26%, PNMR in 
>34wks gestational age is 8.5%.While in induced vaginal 
delivery total PNMR is 42.2%, PNMR in >34wks 
gestational age is 12.24% where as in non-induced cases 
total PNMR is 37.7%  and PNMR in >34wks gestational 
age is15.63%.(Table 6 )  Young and colleagues11 studied 
mortality in late preterm new born babies and found the 
neonatal mortality rate to be higher in preterm babies than 
babies born at term.Overall perinatal mortality rate is 
29.4% (84/285). There were 6 maternal deaths, 5 were 
unbooked cases and 1 case booked previously; earlier 
stabilization of these patients would have prevented 
maternal mortality. A few patients had more than one 
complication at the same time. Causes of death included 
pulmonary embolism, acute LVF, ARDS and 
DIC.Maternal fatality rate is 2.1%. However, many of the 
maternal complications seen in the eclamptic patients 
appeared to arise from delays in the timely management 
of pre-eclamptic patients. 
 
Conclusion 
 
 Incidence of severe pre-eclampsia was 2.03% of 
deliveries, seen commonly in young women below 25 yrs 
of age, nulliparous, with no antenatal care and was seen 
maximum after 34 weeks of pregnancy.  Many patients 
came with various complications which were efficiently 
managed by stabilizing and delivering them early. The BP 
was well controlled with Nifedepine or Labetalol and 
Magnesium sulphate in all cases. Though LSCS group had 
slightly higher perinatal survival, several study groups 
showed higher morbidity after LSCS. Thus, with proper 
evaluation i.e. clinically and by investigations (including 
Doppler), perinatal outcome will be good with vaginal 
delivery by miso induction or LSCS and maternal 
mortality and morbidity will be low.           
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